United States· US:71205-937_c8003a86-3d92-4acb-b8b8-fe52835c83f5
Miglitol
A miglitol product containing miglitol, registered in United States by Proficient Rx LP. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Miglitol is registered in 2 of 19 countries.
Countries holding a registration under ATC A10BF02 (miglitol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Miglitol · ATC A10BF02
2 / 19 countries
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MIGLITOL
- Manufacturer
- Proficient Rx LP
- Country
- United States (US)
- ATC code
- A10BF02
- ATC class
- Miglitol
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc117120593700100 TABLET, COATED in 1 BOTTLE (71205-937-00)
- ndc11712059373030 TABLET, COATED in 1 BOTTLE (71205-937-30)
- ndc11712059376060 TABLET, COATED in 1 BOTTLE (71205-937-60)
- ndc11712059379090 TABLET, COATED in 1 BOTTLE (71205-937-90)
- ndc1171205-937-60
- ndc1171205-937-90
- ndc1171205-937-00
- ndc1171205-937-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
302 interactions on record for miglitol.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Miglitol · interactions on record
302 records
- 1 severe
- 258 moderate
- 43 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Miglitol in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9a019ba-db4c-4e8c-bcb1-d3a7942bd8d7 GET /v1/drugs/c9a019ba-db4c-4e8c-bcb1-d3a7942bd8d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "MIGLITOL",
"productndc": "71205-937",
"dosage_form": "TABLET, COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA203965",
"marketing_category": "ANDA"
}See everything about miglitol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.